Showing 301-310 of 360 results for "".
- Aesthetics Biomedical, Skinceuticals Partner with Vivace Experience Featuring SkinCeuticals C E Ferulichttps://modernaesthetics.com/news/aesthetics-biomedica-skinceuticals-partner-with-vivace-experience-featuring-skinceuticals-c-e-ferulic/2473001/SkinCeuticals is teaming up with Aesthetics Biomedical’s Vivace Fractional Micro Needle Radio Frequency Treatment to create the professional Vivace Experience featuring SkinCeuticals C E Ferulic MaryAnn Guerra, CEO & President of Aesthetics Biomedical states, "Aesthetics
- Allergan Buys Luminera Dermal-Filler Businesshttps://modernaesthetics.com/news/allergan-buys-luminera-dermal-filler-business/2473000/Allergan Aesthetics, an AbbVie company, has acquired Luminera's full dermal filler portfolio and R&D pipeline. Luminera is a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. "
- Industry Responds to COVID-19: BTL to Manufacture Face Masks, Ventilatorshttps://modernaesthetics.com/news/coping-with-covid-19-btl-to-manufacture-face-masks-ventilators/2472997/BTL is revamping several of their manufacturing facilities to provide face masks and ventilators to the medical community. As of September 2020, BTL's European manufacturing facilities have been producing ventilators and masks including 
- Cynosure Taps Vet Dr. Rafael Sierra for R&D Positionhttps://modernaesthetics.com/news/cynosure-taps-vet-rafael-sierra-phd-for-rd-position/2472992/Rafael Sierra, PhD is back at Cynosure. The former Chief Technology Officer is now an R&D Advisor. "Dr. Sierra's passion for the science behind medical aesthetics and inherent knowledge of its clinical application are unparalleled," says Todd
- Gwyneth Paltrow Named Global Face of Xeominhttps://modernaesthetics.com/news/gwyneth-paltrow-named-global-face-of-xeomin-1/2472991/Actress and Goop wellness guru Gwyneth Paltrow is the first global face of Merz Aesthetic’s Xeomin. In this role, Paltrow will be sharing details about what she does to look and feel her best, and will ask women to do the same on social media using #DareToSelfCare. &ldqu
- NYC Dermatologist Dr. Doris Day Joins Nufabrx’s Ad Boardhttps://modernaesthetics.com/news/nyc-dermatologist-dr-doris-day-joins-nufabrxs-ad-board/2472988/New York City dermatologist Doris Day, MD is the newest member of Nufabrx’s advisory board. Nufabrx is an advanced textiles company that has developed a proprietary biomaterial platform that embeds active ingredient
- Here’s What’s Been Happening at Merz Aestheticshttps://modernaesthetics.com/news/heres-whats-been-happening-at-merz-aesthetics/2472979/Merz Aesthetics is launching its new “confidence to be” branding platform following the conclusion of the company’s reorganization. Merz is now three independently operating businesses: medical aesthetics, therapeutics and consumer care. “The new brand
- NYC Plastic Surgeon Dr. Sachin Shridharani Joins Soliton’s Scientific Advisory Boardhttps://modernaesthetics.com/news/sachin-shridharani-md-joins-solitons-scientific-advisory-board/2472973/Sachin Shridharani, MD has joined Soliton, Inc’s Scientific Advisory Board. Soliton, Inc. recently filed for 510(k) premarket clearance with the U.S. Food and Drug Administration (FDA) of its second-generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance o
- Endo’s Qwo Scores FDA Nod for Cellulite Treatmenthttps://modernaesthetics.com/news/endos-qwo-scores-fda-nod-for-cellulite-treatment/2472961/The FDA has given its nod to an entirely new way to address cellulite. Endo Aesthetic’s Qwo (collagenase clostridium histolyticum-aaes) is the first injectable treatment for moderate to severe cellulite of the buttocks in adult women. When fat in cellulite-prone areas swells and e
- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc